Patents Assigned to Dicerna Pharmaaceuticals, Inc. - Justia Patents Search

Patents Assigned to Dicerna Pharmaaceuticals, Inc.

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF ANTITHROMBIN 3 (AT3) BY DOUBLE-STRANDED RNA

Publication number: 20180282723

Abstract: This invention relates to compounds, compositions, and methods useful for reducing AT3 target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Type: Application

Filed: May 9, 2016

Publication date: October 4, 2018

Applicant: Dicerna Pharmaaceuticals, Inc.

Inventors: Bob D. BROWN, Henryk T. DUDEK